Janssen's blockbuster pulmonary arterial hypertension drug Opsumit 10mg (Micronized Macitentan) will drop by 30% on the 1st of next month. In addition to the reimbursement of Maciten, the first generic drug that acquired generic for exclusivity, the drug price cut was applied in a cascading fashion. An addition is applied here, so after a year, even this will disappear and fall further. According to the industry on the 23rd, the Ministry of Health and Welfare is in the process of revising the 'drug benefit list and the maximum benefit amount table'. Opsumit's drug price cut began when first-generic Maciten received insurance benefits this month.

Maciten is the first Opsumit generic, priced at 28,864 won